SBRT2015

Multicentric phase II Lille, Nancy & Nice

80

Patients Sex n (%) M

N = 56

60

43 ( 75.4) 14 ( 24.6)

F

40

Percent

Age,

60 (42 – 80)

20

0

15 20 25 30 35 40 45 50 55 60 65 70 Duration Cetux (days)

Dose and duration

N=56

80

Duration (days)

60

Median (range)

28 (15-70)

Total dose cycle 1 (mg/m²) Median (range)

40

Percent

400 (307-426)

20

77 % response at 3 months

0

500

1000

1500

2000

2500

Total Dose Cetuximab (mgm2)